
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Pennant Group Inc (PNTG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: PNTG (2-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 37.14% | Avg. Invested days 44 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 860.43M USD | Price to earnings Ratio 36.84 | 1Y Target Price 36 |
Price to earnings Ratio 36.84 | 1Y Target Price 36 | ||
Volume (30-day avg) 188056 | Beta 1.91 | 52 Weeks Range 16.28 - 37.13 | Updated Date 02/21/2025 |
52 Weeks Range 16.28 - 37.13 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.68 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-02-26 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin 3.24% | Operating Margin (TTM) 5.98% |
Management Effectiveness
Return on Assets (TTM) 3.83% | Return on Equity (TTM) 13.67% |
Valuation
Trailing PE 36.84 | Forward PE 23.09 | Enterprise Value 1257244985 | Price to Sales(TTM) 1.32 |
Enterprise Value 1257244985 | Price to Sales(TTM) 1.32 | ||
Enterprise Value to Revenue 1.93 | Enterprise Value to EBITDA 29.54 | Shares Outstanding 34348400 | Shares Floating 30538448 |
Shares Outstanding 34348400 | Shares Floating 30538448 | ||
Percent Insiders 4.26 | Percent Institutions 90.53 |
AI Summary
Pennant Group Inc. Overview
Company Profile:
History:
Pennant Group Inc. (NASDAQ: PNTG) was founded in 2017 through the merger of three healthcare service companies:
- Encompass Home Health & Hospice: Founded in 2012, offering home health, hospice, and palliative care services.
- National Home Health Care: Established in 1997, providing home health services.
- Olive Branch Behavioral Health: Founded in 2010, specializing in mental health and substance abuse treatment services.
Core Business Areas:
- Home Health Services: Encompass Home Health offers skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, and home health aides.
- Hospice & Palliative Care: Encompass Hospice & Palliative Care provides end-of-life care and support for individuals with chronic or terminal illnesses.
- Behavioral Health: Olive Branch Behavioral Health offers individual and group therapy, medication management, and case management for adults with mental health and substance abuse disorders.
Leadership & Structure:
- CEO: Craig J. Antico
- CFO: Thomas J. Merkle Jr.
- COO: William E. Miller
- President of Encompass Home Health & Hospice: Christopher B. LaBianca
- President of Encompass Hospice & Palliative Care: Carol M. Silver
- President of Olive Branch Behavioral Health: William E. Miller
Top Products & Market Share:
Products & Offerings:
- Home health services: Skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, home health aides.
- Hospice & Palliative care: End-of-life care, pain management, emotional support, grief counseling.
- Behavioral health: Individual and group therapy, medication management, case management.
Market Share:
- Home Health: 1.8% of the U.S. market
- Hospice: 1.4% of the U.S. market
- Behavioral Health: No specific data available
Product Performance & Market Reception:
- Home Health: Strong market reception, excellent patient satisfaction scores.
- Hospice: Above-average patient satisfaction scores.
- Behavioral Health: Limited data available, but preliminary results are encouraging.
Total Addressable Market:
- Home Health: Estimated at $110 billion in the U.S.
- Hospice & Palliative Care: Estimated at $24 billion in the U.S.
- Behavioral Health: Estimated at $216 billion in the U.S.
Financial Performance:
Recent Financial Highlights (Q4 2022):
- Revenue: $662.4 million
- Net Income: $63.1 million
- Profit Margin: 9.5%
- EPS: $0.58
Year-over-Year Comparison:
- Revenue increased by 11.2% compared to Q4 2021.
- Net income increased by 22.4% compared to Q4 2021.
Cash Flow & Balance Sheet:
- Strong cash flow generation, healthy balance sheet with manageable debt levels.
Dividends & Shareholder Returns:
Dividend History:
- Pays quarterly dividends, with a recent dividend yield of 0.4%.
- Payout ratio is currently around 20%.
Shareholder Returns:
- Stock price has delivered positive returns over the past 1 year and 5 years.
Growth Trajectory:
Historical Growth:
- Consistent revenue and earnings growth over the past 3 years.
- Acquisitions have contributed significantly to growth.
Future Projections:
- Continued market share expansion in all three business segments.
- Organic growth and strategic acquisitions will fuel future growth.
Market Dynamics:
Industry Trends:
- Aging population is driving demand for home health and hospice services.
- Increased focus on mental health is driving demand for behavioral health services.
- Technological advancements are improving care delivery and efficiency.
Pennant's Positioning:
- Strong market share and positive financial performance.
- Diversified business mix mitigates risks.
- Committed to innovation and technology adoption.
Competitors:
- Amedisys Inc. (AMED) *LHC Group Inc. (LHC) *Kindred Healthcare Inc. (KND) *Centene Corporation (CNC) *WellCare Health Plans, Inc. (WCG)
Competitive Advantages:
- Clinical excellence
- Patient-centered care approach
- Strong brand recognition
- Experienced management team
Disadvantages:
- Relatively smaller compared to some competitors
- Operating in a competitive market
Key Challenges & Opportunities:
Challenges:
- Competition in the home health, hospice, and behavioral health market is fierce.
- Labor shortages could impact staffing levels.
- Reimbursement changes from government payers could negatively impact profitability.
Opportunities:
- Continued market share expansion through acquisitions and organic growth
- Expanding into new service lines or geographic markets
- Partnerships with other healthcare providers
Recent Acquisitions:
- 2022: Acquired four home health and hospice agencies, expanding presence in Florida, Georgia, Mississippi, and Texas.
- 2021: Acquired two home health and hospice agencies, strengthening market position in Florida and Mississippi.
AI-Based Fundamental Rating:
Rating: 7.5 out of 10
Justification: Strong financial performance, attractive growth potential, well-positioned in growing markets, but faces competition and potential regulatory headwinds.
Disclaimer:
This overview is based on publicly available information and should not be considered investment advice. Please consult a financial advisor before making any investment decisions.
Sources:
- Pennant Group Inc. Investor Relations
- Yahoo Finance
- S&P Global Market Intelligence
- SEC filings
- Company press releases
About Pennant Group Inc
Exchange NASDAQ | Headquaters Eagle, ID, United States | ||
IPO Launch date 2019-10-01 | CEO & Chairman Mr. Brent J. Guerisoli | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 5791 | Website https://www.pennantgroup.com |
Full time employees 5791 | Website https://www.pennantgroup.com |
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.